Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Dixon

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biotechniques|July 10, 2010
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domainAndrew S Dixon, Carol S Lim
Therapeutic Delivery|November 30, 2010
Controlling subcellular delivery to optimize therapeutic effectMohanad Mossalam, Andrew S Dixon, Carol S Lim
Acta Biomaterialia|September 8, 2021
Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfacesSun Jin Kim, Andrew S Dixon, Shawn C Owen
Biotechnology and Bioengineering|April 2, 2019
Split-enzyme fragment as a single affinity tag that enables protein expression, purification, and functional assaysSun Jin Kim, Samuel T Hatch, Andrew S Dixon, et al.
Scientific Reports|August 17, 2017
A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous ImmunoassaysAndrew S Dixon, Sun Jin Kim, Brett K Baumgartner, et al.
Pharmaceutical Research|December 21, 2011
Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifsAndrew S Dixon, Jonathan E Constance, Tomoyuki Tanaka, et al.
ACS Sensors|May 19, 2021
Homogeneous Immunoassay Using a Tri-Part Split-Luciferase for Rapid Quantification of Anti-TNF Therapeutic AntibodiesSun Jin Kim, Andrew S Dixon, P Chad Adamovich, et al.
Molecular Pharmaceutics|August 23, 2013
A chimeric p53 evades mutant p53 transdominant inhibition in cancer cellsAbood Okal, Mohanad Mossalam, Karina J Matissek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2020
Multivalent HER2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug deliveryD Christopher Radford, Jiyuan Yang, Mai C Doan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biotechniques|July 10, 2010
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domainAndrew S Dixon, Carol S Lim
Therapeutic Delivery|November 30, 2010
Controlling subcellular delivery to optimize therapeutic effectMohanad Mossalam, Andrew S Dixon, Carol S Lim
Acta Biomaterialia|September 8, 2021
Split-enzyme immunoassay to monitor EGFR-HER2 heterodimerization on cell surfacesSun Jin Kim, Andrew S Dixon, Shawn C Owen
Biotechnology and Bioengineering|April 2, 2019
Split-enzyme fragment as a single affinity tag that enables protein expression, purification, and functional assaysSun Jin Kim, Samuel T Hatch, Andrew S Dixon, et al.
Scientific Reports|August 17, 2017
A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous ImmunoassaysAndrew S Dixon, Sun Jin Kim, Brett K Baumgartner, et al.
Pharmaceutical Research|December 21, 2011
Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifsAndrew S Dixon, Jonathan E Constance, Tomoyuki Tanaka, et al.
ACS Sensors|May 19, 2021
Homogeneous Immunoassay Using a Tri-Part Split-Luciferase for Rapid Quantification of Anti-TNF Therapeutic AntibodiesSun Jin Kim, Andrew S Dixon, P Chad Adamovich, et al.
Molecular Pharmaceutics|August 23, 2013
A chimeric p53 evades mutant p53 transdominant inhibition in cancer cellsAbood Okal, Mohanad Mossalam, Karina J Matissek, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2020
Multivalent HER2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug deliveryD Christopher Radford, Jiyuan Yang, Mai C Doan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2009
Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosisAndrew S Dixon, Mudit Kakar, Korbinian M H Schneider, et al.
Pageof 2